CE: The Evolving Treatment Paradigm of HIV Therapy: Addressing Antiretroviral Tolerability and Barriers to Adherence

Pharmacy Times, September 2020, Volume 88, Issue 9

This activity is supported by an educational grant from Janssen Therapeutics, division of Janssen Products, LP.

This activity is supported by an educational grant from Janssen Therapeutics, division of Janssen Products, LP.

EDUCATIONAL OBJECTIVES

At the completion of this activity, the participant will be able to:

  • Explore the most recent data on HIV burden including the issues surrounding antiretroviral therapy (ART)
  • Examine the most recent updates to the Department of Health and Human Services (HHS) guidelines for ART and the current focus to overcome medication tolerability and improve adherence
  • Employ updates to HHS guidelines to appropriately select ART while addressing barriers to adherence such as weight gain, neuropsychiatric tolerability, and polypharmacy
  • Optimize the role of the pharmacist in improving outcomes of patients on HIV treatment along with preventing transmission

FACULTY

Eric K. Farmer, PharmD, BCPS, AAHIVP

HIV Clinical Pharmacist, LifeCare Clinic

Indiana University Health, Academic Health Center

Indianapolis, Indiana

Brooke N. Stevens, PharmD, BCPS, AAHIVP

HIV Clinical Pharmacist, LifeCare Clinic

Indiana University Health, Academic Health Center

Indianapolis, Indiana

TARGET AUDIENCE: Retail pharmacists, specialty pharmacists

ACTIVITY TYPE: Application

RELEASE DATE: September 15, 2020

EXPIRATION DATE: October 15, 2021

ESTIMATED TIME TO COMPLETE ACTIVITY: 2.0 hours

FEE: This lesson is offered for free at www.pharmacytimes.org.